1. NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
- Author
-
Kathryn Bobb, Dileep D. Monie, Matthew McCormick, Steven Jacobson, Dibyadeep Datta, Drago R Sliskovic, Jie Zhang, Jeffrey Meshulam, Richard V. Turner, and Unsong Oh
- Subjects
lcsh:Immunologic diseases. Allergy ,endocrine system ,biology ,business.industry ,CD69 ,food and beverages ,virus diseases ,Peripheral blood mononuclear cell ,Molecular biology ,Pathogenesis ,Immune system ,Infectious Diseases ,immune system diseases ,hemic and lymphatic diseases ,Virology ,Immunology ,Meeting Abstract ,biology.protein ,Medicine ,Htlv i associated myelopathy ,IL-2 receptor ,Antibody ,business ,lcsh:RC581-607 ,STAT5 - Abstract
Evidence suggests that HTLV-I-induced immune activation plays a key role in the pathogenesis of HAM/TSP. The HTLV-I-encoded transactivating protein Tax is known to activate nuclear factor kappa B (NFkB), a key host signaling pathway regulating immune response, but the contribution of the NFkB pathway to the immune activation associated with HAM/TSP has yet to be fully defined. We examined NFkB activation in peripheral-blood mononuclear cells (PBMC) from subjects with HAM/TSP, and tested the effect of NFkB inhibition on key ex vivo correlates of immune activation in HAM/TSP. We examined the role of NFkB activation during immune activation associated with HAM/TSP by using small molecule NFkB inhibitors, including a newly developed selective inhibitor of NFkB, PBS-1086. NFkB activation was assessed in peripheral-blood mononuclear cells (PBMC) from subjects with HAM/TSP and in healthy donors (HD). Nuclear translocation of the NFkB RelA was significantly higher in PBMC from subjects with HAM/TSP compared to HD (p=0.032) following short-term (20 h) culture, indicating increased activation of the NFkB pathway in HAM/TSP. Treatment with the small molecule inhibitor PBS-1086 reduced NFkB activation (p
- Published
- 2011